<?xml version="1.0" encoding="UTF-8"?><!-- Converted from Majour with majour2a++ V1.11 --><!--Automatically converted from version 2.3 to 2.4-->

<!DOCTYPE Publisher
  PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN" "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>

   <PublisherInfo>

      <PublisherName>Springer-Verlag</PublisherName>

      <PublisherLocation>Berlin Heidelberg</PublisherLocation>

   </PublisherInfo>

   <Journal>

      <JournalInfo JournalProductType="Legacy" NumberingStyle="Unnumbered">

         <JournalID>105</JournalID>

         <JournalPrintISSN>0017-8470</JournalPrintISSN>

         <JournalSPIN/>

         <JournalTitle>Der Hautarzt</JournalTitle>

         <JournalSubTitle>Zeitschrift für Dermatologie, Allergologie, Venerologie und verwandte Gebiete</JournalSubTitle>

         <JournalAbbreviatedTitle>Hautarzt</JournalAbbreviatedTitle>
         <JournalSubjectGroup>
            <JournalSubject Type="Primary">Legacy</JournalSubject>
         </JournalSubjectGroup>

      </JournalInfo>

      <Volume>

         <VolumeInfo VolumeType="Regular">
            <VolumeIDStart>46</VolumeIDStart>
            <VolumeIDEnd>46</VolumeIDEnd>
            <VolumeIssueCount/>
         </VolumeInfo>

         <Issue IssueType="Regular">

            <IssueInfo TocLevels="0">

               <IssueIDStart>5</IssueIDStart>

               <IssueIDEnd>5</IssueIDEnd>

               <IssueHistory>

                  <PrintDate>

                     <Year>1995</Year>

                     <Month>5</Month>

                     <Day/>

                  </PrintDate>

                  <CoverDate>

                     <Year>1995</Year>

                     <Month>5</Month>

                  </CoverDate>

               </IssueHistory>

               <IssueCopyright>

                  <CopyrightHolderName>Springer-Verlag Berlin Heidelberg</CopyrightHolderName>

                  <CopyrightYear>1995</CopyrightYear>

               </IssueCopyright>

            </IssueInfo>

            <Article ID="Art1">

               <ArticleInfo Language="En" ArticleType="OriginalPaper" NumberingStyle="Unnumbered" ContainsESM="No" TocLevels="0">

                  <ArticleID>50460343.105</ArticleID>

                  <ArticleDOI>10.1007/s001050050264</ArticleDOI>

                  <ArticleTitle Language="De">Granuloma anulare disseminatum als seltene
Nebenwirkung von Allopurinol</ArticleTitle>

                  <ArticleTitle Language="En">Allopurinol-induced generalized granuloma annulare</ArticleTitle>

                  <ArticleCategory/>

                  <ArticleFirstPage>343</ArticleFirstPage>

                  <ArticleLastPage>345</ArticleLastPage>

                  <ArticleCopyright>

                     <CopyrightHolderName>Springer-Verlag Berlin Heidelberg</CopyrightHolderName>

                     <CopyrightYear>1995</CopyrightYear>

                  </ArticleCopyright>
                  <ArticleGrants>
                     <MetadataGrant Grant="OpenAccess"/>
                     <AbstractGrant Grant="OpenAccess"/>
                     <BodyPDFGrant Grant="Restricted"/>
                     <BodyHTMLGrant Grant="Restricted"/>
                     <BibliographyGrant Grant="Restricted"/>
                     <ESMGrant Grant="Restricted"/>
                  </ArticleGrants>

               </ArticleInfo>

               <ArticleHeader>

                  <AuthorGroup>

                     <Author AffiliationIDS="A1">

                        <AuthorName DisplayOrder="Western">

                           <GivenName>D.</GivenName>

                           <FamilyName>Becker</FamilyName>

                        </AuthorName>

                     </Author>

                     <Author AffiliationIDS="A1">

                        <AuthorName DisplayOrder="Western">

                           <GivenName>A.</GivenName>

                           <FamilyName>Enk</FamilyName>

                        </AuthorName>

                     </Author>

                     <Author AffiliationIDS="A1">

                        <AuthorName DisplayOrder="Western">

                           <GivenName>W.</GivenName>

                           <FamilyName>Bräuninger</FamilyName>

                        </AuthorName>

                     </Author>

                     <Author AffiliationIDS="A1">

                        <AuthorName DisplayOrder="Western">

                           <GivenName>J.</GivenName>

                           <FamilyName>Knop</FamilyName>

                        </AuthorName>

                     </Author>

                     <Affiliation ID="A1">

                        <OrgName>Hautklinik (Direktor: Prof. Dr. J. Knop) der
Johannes Gutenberg-Universität, Mainz
</OrgName>

                        <OrgAddress>

                           <Street/>

                           <Postbox/>

                           <Postcode/>

                           <City/>

                           <State/>

                           <Country>DE</Country>

                        </OrgAddress>

                     </Affiliation>

                  </AuthorGroup>

                  <Abstract ID="Abs1" Language="De">

                     <Heading>Zusammenfassung</Heading>

                     <Para>

                        <Emphasis Type="Italic"> Es wird über 2 Patienten berichtet,
die unter Langzeittherapie einer Hyperurikämie mit Allopurinol (300
mg/d) ein histologisch gesichertes disseminiertes Granuloma annulare
entwickelten. Andere Begleiterkrankungen, insbesondere ein Diabetes
mellitus, lagen nicht vor. Nach Absetzen der Allopurinolmedikation
bildeten sich die Hautveränderungen ohne Rezidive zurück, die
wieder einsetzende Hyperurikämie konnte mit purinarmer Diät
und medikamentös unter Meidung von Allopurinol beherrscht werden.
Die zeitliche Abhängigkeit der Erkrankungsverläufe von der
Allopurinoltherapie legt einen kausalen Zusammenhang nahe, sodaß
wir beide Fälle als seltene, aber ernstzunehmende Nebenwirkung von
Allopurinol einordnen. Dies sollte zu einer kritischen
Überprüfung der Medikamentenanamnese bei disseminierten Formen
des Granuloma anulare veranlassen.</Emphasis>

                     </Para>

                  </Abstract>

                  <Abstract ID="Abs2" Language="En">

                     <Heading>Summary</Heading>

                     <Para> During long-term therapy of
hyperuricaemia with allopurinol (300 mg/d) two patients developed
generalized granuloma annulare. The diagnoses were confirmed by
histology; concomitant diseases, especially diabetes mellitus, were not
detectable. Following discontinuation of allopurinol therapy, cutaneous
granulomas healed without relapse. Hyperuricaemia could be controlled by
low-purine diet and medication avoiding allopurinol. The clinical
history of our two patients suggested a causal connection between
allopurinol therapy and generalized granuloma annulare. For this reason
we rate the development of this disease in both cases as a rare but
significant side effect of allopurinol. This should give rise to
critical assessment of concomitant drug therapy during development of
generalized granuloma annulare.</Para>

                  </Abstract>

                  <KeywordGroup Language="En">

                     <Keyword>Key words Generalized granuloma annulare — Allopurinol — Drug side effect</Keyword>

                  </KeywordGroup>

                  <KeywordGroup Language="De">

                     <Keyword>Schlüsselwörter Granuloma anulare disseminatum — Allopurinol — Medikamentennebenwirkung</Keyword>

                  </KeywordGroup>

                  <ArticleNote Type="Misc">

                     <SimplePara>Eingegangen am 15. Februar 1994¶ Angenommen am 5. April
1994</SimplePara>

                  </ArticleNote>

               </ArticleHeader>

               <NoBody/>

            </Article>

         </Issue>

      </Volume>

   </Journal>

</Publisher>